These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 31684771)

  • 1. The Effects of Adjuvant Tamoxifen Use on Macula Pigment Epithelium Optical Density, Visual Acuity and Retinal Thickness in Patients with Breast Cancer.
    Bicer T; Imamoglu GI; Caliskan S; Bicer BK; Gurdal C
    Curr Eye Res; 2020 May; 45(5):623-628. PubMed ID: 31684771
    [No Abstract]   [Full Text] [Related]  

  • 2. OCT Angiography Findings of Tamoxifen Retinopathy: Similarity with Macular Telangiectasia Type 2.
    Lee S; Kim HA; Yoon YH
    Ophthalmol Retina; 2019 Aug; 3(8):681-689. PubMed ID: 31068263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dosage-dependent reduction of macular pigment optical density in female breast cancer patients receiving tamoxifen adjuvant therapy.
    Lim IL; Loo AVP; Subrayan V; Khang TF; See MH; Alip A; Taib NAM
    Breast; 2018 Jun; 39():117-122. PubMed ID: 29660599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized, double-blind, placebo-controlled study of zeaxanthin and visual function in patients with atrophic age-related macular degeneration: the Zeaxanthin and Visual Function Study (ZVF) FDA IND #78, 973.
    Richer SP; Stiles W; Graham-Hoffman K; Levin M; Ruskin D; Wrobel J; Park DW; Thomas C
    Optometry; 2011 Nov; 82(11):667-680.e6. PubMed ID: 22027699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spectral Domain OCT Imaging Techniques in Tamoxifen Retinopathy.
    Neuville J; Yevseyenkov V
    Optom Vis Sci; 2015 Feb; 92(2):e55-9. PubMed ID: 25525894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinal structural changes in patients receiving tamoxifen therapy by spectral-domain optical coherence tomography.
    Bolukbasi S; Kandemir Gursel O; Cakir A; Erden B; Karatas G
    Cutan Ocul Toxicol; 2020 Jun; 39(2):115-121. PubMed ID: 32100607
    [No Abstract]   [Full Text] [Related]  

  • 7. Macula pigment optical densitometry changes in hydroxychloroquine use.
    Kabataş N; Özateş S; Avarisli NA; Kakil SB; Özişler C
    Cutan Ocul Toxicol; 2021 Jun; 40(2):115-118. PubMed ID: 33757380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maculopathy following extended usage of Clomiphene citrate.
    Tunc M
    Eye (Lond); 2014 Sep; 28(9):1144-6. PubMed ID: 24858527
    [No Abstract]   [Full Text] [Related]  

  • 9. Influence of macular oedema on the measurement of macular pigment optical density.
    Thiele S; Rauscher FG; Wiedemann P; Dawczynski J
    Graefes Arch Clin Exp Ophthalmol; 2016 Mar; 254(3):455-65. PubMed ID: 26100452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudocystic foveal cavitation in tamoxifen retinopathy.
    Doshi RR; Fortun JA; Kim BT; Dubovy SR; Rosenfeld PJ
    Am J Ophthalmol; 2014 Jun; 157(6):1291-1298.e3. PubMed ID: 24582991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Electrophysiological studies in breast carcinoma patients with tamoxifen retinopathy].
    Kuchenbecker J; Pump-Schmidt C; Olbricht S; Weise W; Behrens-Baumann W
    Ophthalmologe; 2001 Jan; 98(1):81-5. PubMed ID: 11220276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Unusual symptoms for tamoxifen-associated maculopathy].
    Hager T; Hoffmann S; Seitz B
    Ophthalmologe; 2010 Aug; 107(8):750-2. PubMed ID: 20393723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvements in visual acuity and macular morphology following cessation of anti-estrogen drugs in a patient with anti-estrogen maculopathy resembling macular telangiectasia type 2: a pathogenic hypothesis.
    Shinkai A; Saito W; Hashimoto Y; Ishida S
    BMC Ophthalmol; 2019 Dec; 19(1):267. PubMed ID: 31888549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tomographic assessment of vitreous surgery for diabetic macular edema.
    Otani T; Kishi S
    Am J Ophthalmol; 2000 Apr; 129(4):487-94. PubMed ID: 10764858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tamoxifen retinopathy: a case series of clinical and functional data].
    Ritter C; Renner AB; Wachtlin J; Bechrakis NE; Krause L
    Ophthalmologe; 2008 Jun; 105(6):544-9. PubMed ID: 18415107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined hamartoma of the retina and retinal pigment epithelium in 77 consecutive patients visual outcome based on macular versus extramacular tumor location.
    Shields CL; Thangappan A; Hartzell K; Valente P; Pirondini C; Shields JA
    Ophthalmology; 2008 Dec; 115(12):2246-2252.e3. PubMed ID: 18995912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tamoxifen retinopathy.
    Kaiser-Kupfer MI; Lippman ME
    Cancer Treat Rep; 1978 Mar; 62(3):315-20. PubMed ID: 647693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and Risk Factors of Tamoxifen Retinopathy.
    Kim HA; Lee S; Eah KS; Yoon YH
    Ophthalmology; 2020 Apr; 127(4):555-557. PubMed ID: 31813590
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of Macular Pigment Optical Density in Glaucoma Patients and Healthy Subjects - A Prospective Diagnostic Study.
    Bruns Y; Junker B; Boehringer D; Framme C; Pielen A
    Clin Ophthalmol; 2020; 14():1011-1017. PubMed ID: 32308361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Macular diseases--application of automated static perimetry and optical coherence tomography].
    Iijima H
    Nippon Ganka Gakkai Zasshi; 2000 Dec; 104(12):943-59. PubMed ID: 11193945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.